Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory
暂无分享,去创建一个
G. Hutchins | G. Sledge | K. Kopecky | S. Badve | R. Emerson | A. Storniolo | K. Miller | S. Soule | R. Goulet | C. Calley